Published • loading... • Updated
TOBY Receives FDA Breakthrough Device Designation for Its Urine-Based Alzheimer's Disease Diagnostic Test
Summary by Star Local
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
FDA Grants Breakthrough Designation to Urine-Based Alzheimer’s Test
The test uses urinary volatile organic compound patterns and machine learning to aid in the diagnosis of Alzheimer’s disease. TOBY Inc announced that the Food and Drug Administration (FDA) granted Breakthrough Device Designation to its urine-based Alzheimer’s disease diagnostic test. The designation recognizes the potential of the TOBY Test for Alzheimer’s Disease to aid in diagnosis through a non-invasive urine sample, addressing a need for acc…
NewswiseReposted by 
Star Local
Star LocalTOBY Receives FDA Breakthrough Device Designation for Its Urine-Based Alzheimer's Disease Diagnostic Test
TOBY, Inc., a biotechnology company developing non-invasive disease detection technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the TOBY Test for Alzheimer's Disease.
·Charlottesville, United States
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
